Physician profile
Athanasios Thomaides
NPI 1134388853
$56,821.18
in general payments reported to CMS, 2019-2025
34 companies · $7,999 in 2025
The $7,999 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,954 · 2020: $5,329 · 2021: $13K · 2022: $3,444 · 2023: $14K · 2024: $9,895 · 2025: $7,999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $8,804 · Travel and Lodging: $4,664 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,175.00 |
| Food and Beverage | $8,803.70 |
| Travel and Lodging | $4,664.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,875.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $14,695.09 | 2020-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic, INC. | $12,813.66 | 2021-2025 | Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan, Micra |
| Medical Device Business Services, INC. | $12,750.00 | 2023-2025 | Carto 3 |
| Abbott Laboratories | $6,451.82 | 2019-2025 | Aveir, Ensite, Jot Dx |
| Medtronic Vascular, INC. | $3,940.99 | 2019-2020 | |
| Biosense Webster, INC. | $1,616.75 | 2020-2025 | Carto 3 |
| Philips North America LLC | $1,068.89 | 2020-2025 | (9520) Igt Devices Undivided, Ecc Solutions, Laser Parts Other |
| Boston Scientific Corporation | $1,016.54 | 2022-2025 | Emblem Mri S-Icd, Clinical Trial Product, Accolade Sr |
| Pfizer INC. | $246.37 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $220.52 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.86 | 2019-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $184.92 | 2023-2025 | Assure Wcd |
| Amgen INC. | $181.28 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $173.07 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $169.06 | 2020-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $136.89 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $135.74 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.36 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $79.90 | 2020-2024 | Wainua |
| Lexicon Pharmaceuticals, INC. | $75.34 | 2023-2024 | Inpefa |
| Cardiva Medical, INC. | $72.88 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Bridgebio Pharma, INC. | $70.78 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $61.84 | 2025 | |
| Sanofi-Aventis U.S. LLC | $59.51 | 2024 | |
| Angiodynamics, INC. | $45.06 | 2024 | Angiovac |
| Actelion Pharmaceuticals US, INC. | $40.38 | 2025 | Opsumit |
| Irhythm Technologies, INC. | $38.31 | 2020-2021 | |
| Esperion Therapeutics, INC. | $27.86 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $21.75 | 2024 | Arcalyst |
| Biotronik INC. | $20.84 | 2023 | Acticor 7 Vr-T Dx |
| Elutia, INC. | $19.19 | 2022 | |
| Alnylam Pharmaceuticals INC. | $16.21 | 2024 | Amvuttra |
| Regeneron Healthcare Solutions, INC. | $16.07 | 2019 | |
| Lundbeck LLC | $14.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,551.53 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athanasios Thomaides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.